Search:

Filter:

Sort:

Affidavit, USA v Rodrigo de Medeiros Siqueira, October 2025

February 6, 2026

United States District Court District of Massachusetts USA v Rodrigo De Medeiros Siqueira Affidavit Filed October 10, 2025 Read the document. 

Information, USA v Rodrigo de Medeiros Siqueira, December 2025

February 6, 2026

United States District Court District of Massachusetts USA v Rodrigo De Medeiros Siqueira Information Filed December 11, 2025 Read the document. 

FDA Alert: Dietary supplement recall due to undeclared drug ingredient

February 5, 2026

The FDA has posted a notice for a dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients.

PSM statement on ‘deeply concerning’ compounding of GLP-1 weight-loss pills

February 5, 2026

PSM Executive Director Shabbir Imber Safdar released the following statement in response to news that Hims & Hers is now compounding pill versions of a newly approved GLP-1 weight-loss drug.

Four things Congress should do for patient safety in the rest of the 119th

February 5, 2026

This post outlines practical steps Congress should take to strengthen pharmaceutical border security, reinforce regulatory oversight, and protect patients.

February 2, 2026: Med spa owner charged with posing as a registered nurse

February 3, 2026

A patient at a North Dakota med spa told investigators she had to coach the clinic owner through the IV administration process. The owner allegedly presented herself as a registered nurse, despite holding no medical licenses.

Prescription Drug Affordability Board Activity, December 2025

February 2, 2026

Prescription Drug Affordability Board Activity, December 2025 Activities Summary Colorado:  In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on December 8, 2025  to review a draft of its annual…

PSM endorses Iowa HSB 591 to strengthen med spa oversight for Iowans

January 28, 2026

The bill will protect Iowa’s patients by closing enormous regulatory gaps in the med spa and wellness industry.

January 26, 2025: Health Canada warns Canadians about the dangers of unapproved GLP-1s

January 26, 2026

The agency has found websites and social media advertisements displaying official Health Canada logos with fake endorsements to mislead consumers, and said that it doesn’t endorse health products or permit its logo to be used in ads that promote them.

January 20, 2026: PSM research leads Google to enforce its pill press ad policy

January 21, 2026

Reporting on PSM-led research led Google to suppress pill press ads, Congressman Raja Krishnamoorthi sent letters to shippers of weight loss drugs and API, and a former nurse was charged with distributing counterfeit Ozempic.